Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon

P Kramata, I Votruba, B Otova and A Holy

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of The Czech Republic, Prague, The Czech Republic.

Based on the powerful virostatic potency and cytostatic activity of adenine, 2,6-diaminopurine, and guanine derivatives of acyclic phosphonate nucleotide analog (S)-1-(3-hydroxy-2- phosphonomethoxypropyl) and 9-(2-phosphonomethoxyethyl) series, we examined the inhibitory potencies of their diphosphates [(S)-9-(3- hydroxy-2-phosphonomethoxypropyl)adenine diphosphate (HPMPApp), 9-(2- phosphonomethoxyethyl)adenine diphosphate, 9-(2-phosphonomethoxyethyl)- 2,6-diaminopurine diphosphate (PMEDAPpp), and 9-(2- phosphonomethoxyethyl)guanine diphosphate, analogs of nucleoside 5'- triphosphates] toward cellular DNA polymerases alpha, delta, and epsilon (isolated from tumors of T cell spontaneous acute lymphoblastic leukemia in Sprague-Dawley inbred rats). Kinetic measurements (K(m), K(i), and V(max)) of synthetic homopolymeric template primers have shown that HPMPApp is a selective and potent inhibitor of polymerase epsilon, whereas PMEDAPpp strongly inhibits polymerase delta. These two compounds may be useful for elucidating the roles of polymerases delta and epsilon. Of the nucleotide analogs tested, 9-(2- phosphonomethoxyethyl) guanine diphosphate is the most efficient inhibitor of polymerases alpha and epsilon, whereas the diphosphate of 9-(2-phosphonomethoxyethyl) adenine, the therapeutically important agent adefovir, inhibits polymerases alpha and epsilon relatively poorly and exerts only moderate inhibition of polymerase delta. These data are quite consistent with previously reported cytostatic activity of these nucleotide analogs. All of the enzymes studied catalyze the incorporation of 9-(2-phosphonomethoxyethyl)adenine, 9-(2- phosphonomethoxyethyl)-2, 6-diaminopurine, and (S)-9-(3-hydroxy-2- phosphonomethoxypropyl)adenine into DNA chain. 9-(2- Phosphonomethoxyethyl)adenine diphosphate and PMEDAPpp were confirmed to be DNA chain terminators. On the other hand, HPMPApp formed poly(dT)/oligo(dA(18)-[(S)-9-(3-hydroxy-2-phosphonomethoxypropyl)a denine]2-4 structures.

Volume 49, Issue 6, pp. 1005-1011, 06/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				W. C. Magee, K. A. Aldern, K. Y. Hostetler, and D. H. Evans Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand Antimicrob. Agents Chemother., February 1, 2008; 52(2): 586 - 597. [Abstract] [Full Text] [PDF]

				G Dusheiko and N Antonakopoulos Current treatment of hepatitis B Gut, January 1, 2008; 57(1): 105 - 124. [Full Text] [PDF]

				S. Botros, S. William, O. Hammam, Z. Zidek, and A. Holy Activity of 9-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]Adenine against Schistosomiasis mansoni in Mice Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3853 - 3858. [Abstract] [Full Text] [PDF]

				E. De Clercq Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections Clin. Microbiol. Rev., October 1, 2003; 16(4): 569 - 596. [Abstract] [Full Text] [PDF]

				L. Leblond, G. Attardo, B. Hamelin, D. Y. Bouffard, N. Nguyen-Ba, and H. Gourdeau BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-yl-methyl) tetrahydrofuran]: A Cyclic Nucleoside Phosphonate with Antitumor Activity Mol. Cancer Ther., July 1, 2002; 1(9): 737 - 746. [Abstract] [Full Text] [PDF]

				G. Birkus, M. Hajek, P. Kramata, I. Votruba, A. Holy, and B. Otova Tenofovir Diphosphate Is a Poor Substrate and a Weak Inhibitor of Rat DNA Polymerases {alpha}, {delta}, and {varepsilon} Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1610 - 1613. [Abstract] [Full Text] [PDF]

				J. Kahn, S. Lagakos, M. Wulfsohn, D. Cherng, M. Miller, J. Cherrington, D. Hardy, G. Beall, R. Cooper, R. Murphy, et al. Efficacy and Safety of Adefovir Dipivoxil With Antiretroviral Therapy: A Randomized Controlled Trial JAMA, December 22, 1999; 282(24): 2305 - 2312. [Abstract] [Full Text] [PDF]

				P. Kramata and K. M. Downey 9-(2-Phosphonylmethoxyethyl) Derivatives of Purine Nucleotide Analogs: A Comparison of Their Metabolism and Interaction with Cellular DNA Synthesis Mol. Pharmacol., December 1, 1999; 56(6): 1262 - 1270. [Abstract] [Full Text]

				S. Hatse, D. Schols, E. D. Clercq, and J. Balzarini 9-(2-Phosphonylmethoxyethyl)adenine Induces Tumor Cell Differentiation or Cell Death by Blocking Cell Cycle Progression through the S Phase Cell Growth Differ., June 1, 1999; 10(6): 435 - 446. [Abstract] [Full Text]

				P. Kramata, K. M. Downey, and L. R. Paborsky Incorporation and Excision of 9-(2-Phosphonylmethoxyethyl)guanine (PMEG) by DNA Polymerase delta  and epsilon  in Vitro J. Biol. Chem., August 21, 1998; 273(34): 21966 - 21971. [Abstract] [Full Text] [PDF]

				M. K. Bijsterbosch, L. J. J. W. Smeijsters, and T. J. C. van Berkel Disposition of the Acyclic Nucleoside Phosphonate (S)-9(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1146 - 1150. [Abstract] [Full Text]

				V. M. Pisarev, S.-H. Lee, M. C. Connelly, and A. Fridland Intracellular Metabolism and Action of Acyclic Nucleoside Phosphonates on DNA Replication Mol. Pharmacol., July 1, 1997; 52(1): 63 - 68. [Abstract] [Full Text]